Neuronal NO Mediates Cerebral Vasodilator Responses to K + in Hypertensive Rats
- 1 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 39 (4) , 880-885
- https://doi.org/10.1161/01.hyp.0000013056.74554.ce
Abstract
Potassium ion (K + ) normally causes cerebral vasodilatation by activating inwardly rectifying K + (K IR ) channels. We tested whether chronic hypertension affects the magnitude and/or mechanism of K + -induced cerebral vasodilatation in vivo. Basilar artery responses were examined in anesthetized Wistar-Kyoto (WKY; mean arterial pressure, 114±4 mm Hg) and spontaneously hypertensive (SHR; 176±3 mm Hg) rats. In WKY, elevating cerebrospinal fluid K + concentration from 3 mmol/L to 5 and 10 mmol/L caused vasodilatation (percent maximum, 12±1 and 48±7, respectively). The response to 5 mmol/L K + was greater in SHR (percent maximum, 17±2 [ P IR channel inhibitor, barium ion (Ba 2+ , 100 μmol/L) selectively inhibited dilator responses to 5 and 10 mmol/L K + by ≈75% in WKY. In SHR, Ba 2+ had no effect on the response to 5 mmol/L K + , and only partially inhibited (by ≈40%) the response to 10 mmol/L K + . The nonselective NO synthase (NOS) inhibitor Nω-nitro- l -arginine methyl ester, the neuronal NOS (nNOS) inhibitor 1-(2-trifluromethyl-phenyl)imidazole, and the N -type calcium channel inhibitor ω-conotoxin GVIA, were all without effect in WKY, but markedly inhibited the response to 5 mmol/L K + in SHR. When applied together with Ba 2+ , each of these inhibitors also profoundly reduced responses to 10 mmol/L K + in SHR. Immunostaining of basilar arteries revealed that the perivascular nNOS-containing nerve plexus was denser in SHR. Thus, K + dilates the normotensive basilar artery predominantly via K IR channel activation. During chronic hypertension, small physiological elevations in K + dilate the basilar artery by an nNOS-dependent mechanism that appears to be upregulated in a compensatory manner.Keywords
This publication has 16 references indexed in Scilit:
- ROLE OF THE ENDOTHELIUM IN THE GENESIS OF CARDIOVASCULAR DISEASEClinical and Experimental Pharmacology and Physiology, 1996
- Inhibition of nitric oxide synthase by 1‐(2‐trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effectsBritish Journal of Pharmacology, 1996
- Nitric Oxide Modulates the CBF Response to Increased Extracellular PotassiumJournal of Cerebral Blood Flow & Metabolism, 1995
- Nitric oxide synthase-containing neural processes on large cerebral arteries and cerebral microvesselsBrain Research, 1993
- Possible Origins and Distribution of Immunoreactive Nitric Oxide Synthase-Containing Nerve Fibers in Cerebral ArteriesJournal of Cerebral Blood Flow & Metabolism, 1993
- Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.Proceedings of the National Academy of Sciences, 1990
- Inhibitory effects of L-NG-nitro-arginine on the synthesis of EDRF and the cerebroarterial response to vasodilator nerve stimulationLife Sciences, 1990
- Omega-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle.Proceedings of the National Academy of Sciences, 1987
- Purification and sequence of a presynaptic peptide toxin from Conus geographus venomBiochemistry, 1984
- Extracellular Potassium in the Mammalian Central Nervous SystemAnnual Review of Physiology, 1979